Search research articles
Contact Us
Filters
Showing results (311-320 of 333) with videos related to
Page
of 34
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2014
Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial
E Élez, I Kocáková, T Höhler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2001
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer
O Rick, C Bokemeyer, J Beyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2008
[18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial
M de Wit, W Brenner, M Hartmann, et al.
ESMO Open
|
September 6, 2024
High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT
S Secondino, M Badoglio, G Rosti, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
October 29, 2000
[Interdisciplinary consensus on diagnosis and therapy of testicular tumors. Results of an update conference based on evidence-based medicine. German Testicular Cancer study Group (GTCSG)]
R Souchon, S Krege, H J Schmoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2003
Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952
C-H Köhne, J Wils, M Lorenz, et al.
British Journal of Cancer
|
February 24, 2024
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database
C S Karapetis, H Liu, M J Sorich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2005
Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986
C-H Köhne, E van Cutsem, J Wils, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 11, 2007
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
C-H Köhne, J De Greve, J T Hartmann, et al.
The Journal of Pathology
|
June 21, 2008
Stem cell factor as a novel diagnostic marker for early malignant germ cells
H Stoop, F Honecker, G J M van de Geijn, et al.
Page
of 34
Search research articles
Search
Showing results (311-320 of 333) with videos related to
Sort By:
Page
of 34
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2014
Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial
E Élez, I Kocáková, T Höhler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2001
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer
O Rick, C Bokemeyer, J Beyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2008
[18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial
M de Wit, W Brenner, M Hartmann, et al.
ESMO Open
|
September 6, 2024
High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT
S Secondino, M Badoglio, G Rosti, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
October 29, 2000
[Interdisciplinary consensus on diagnosis and therapy of testicular tumors. Results of an update conference based on evidence-based medicine. German Testicular Cancer study Group (GTCSG)]
R Souchon, S Krege, H J Schmoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2003
Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952
C-H Köhne, J Wils, M Lorenz, et al.
British Journal of Cancer
|
February 24, 2024
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database
C S Karapetis, H Liu, M J Sorich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2005
Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986
C-H Köhne, E van Cutsem, J Wils, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 11, 2007
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
C-H Köhne, J De Greve, J T Hartmann, et al.
The Journal of Pathology
|
June 21, 2008
Stem cell factor as a novel diagnostic marker for early malignant germ cells
H Stoop, F Honecker, G J M van de Geijn, et al.
Page
of 34